Article Text

SP0024 Microparticles in haemostasis and thrombosis
  1. N. Mackman
  1. Medicine, Unc-Ch, Chapel Hill, United States


Microparticles (MPs) (also known as microvesicles) are small membrane vesicles that are released from activated and apoptotic cells. They are defined as 0.1-1 μm in diameter and are therefore larger than exosomes. Formation of MPs requires activation of an ATP-dependent lipid transporter called scramblase that translocated phosphatidylserine (PS) from the inner to outer leaflet. Subsequent membrane blebbing is followed by release of a MP. MPs are procoagulant because the exposed PS provides a docking site for the assembly of different coagulation protease complexes. In addition, the presence of the transmembrane glycoprotein called tissue factor (TF) increases their procoagulant activity. Levels of TF-positive MPs are increased in a variety of diseases, including acute coronary syndromes, sepsis, diabetes, sickle cell disease and cancer. Hyperlipidemia induces TF expression in circulating monocytes and these cells subsequently release TF-positive MPs that may contribute to arterial thrombosis after rupture of atherosclerotic plaques. In cancer, tumors release high levels of TF-positive MPs into the circulation and they may trigger venous thrombosis. These studies suggest that levels of TF-positive MPs can be used clinically to assess thrombotic risk in different diseases.

Disclosure of Interest N. Mackman Consultant for: Merck

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.